Home » Endosense Closes $36 Million Series B Financing
Endosense Closes $36 Million Series B Financing
Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received $36 million in Series B financing.
News Blaze
News Blaze
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May